Webcast/CME - Finasteride and Prostate Cancer Prevention: The Latest Chapter

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Prostate Cancer

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Prostate Cancer

	Primary Care Update in Urology
	Prostate Cancer: Recent Developments Relevant for Internal Medicine Physicians
	Emerging Research May Improve Prostate Cancer Treatment

Recent news - Prostate Cancer

	Propagation of Human Spermatogonial Stem Cells In Vitro - (JAMA)
	TopAbstracts in Prostate Cancer 11/11/2009 - (DGNews)
	TopAbstracts in Prostate Cancer 10/28/2009 - (DGNews)
	Rethinking screening for breast cancer and prostate cancer - (JAMA)
	Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy - (JAMA)

Recent cases - Prostate Cancer

	Incidental Carcinoma of the Prostate Gland Presenting with Initial Manifestation of Disseminated Intravascular Coagulopathy (Dic) in a Middle Aged Man: A Case Report
	Non-Prostatic Pathology on Prostate Needle-Biopsy - Colorectal Carcinoid: A Case Report
	A 70-Year-Old Male Having Advanced Prostate Cancer Presenting with Hypercalcemia and Diffuse Osteoblastic Bone Metastases: A Case Report
	A Dramatic, Objective Antiandrogen Withdrawal Response: Case Report and Review of the Literature
	Anejaculation as an Atypical Presentation of Prostate Cancer: A Case Report

personal edition > prostate cancer > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Finasteride and Prostate Cancer Prevention: The Latest Chapter

Presented by:	The University of Nebraska Medical Center, Center for Continuing Education
Lecturer	Several lecturers
Approximate duration:	1 hr.
Summary points:	In this text-based CME programme, an oncology expert summarises the initial findings of the Prostate Cancer Prevention Trial, and explains how finasteride may affect prostate cancer detection by prostate-specific antigen testing or digital rectal examination.
Accreditation:	The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE provider number is 447-000-08-423-H04-P. Expiration date:: November 30, 2009.
Other:	Text-only CE.

Additional Information